Literature DB >> 16762440

Influence of diabetes mellitus on in-hospital mortality in patients with acute myocardial infarction in Japan: a report from TAMIS-II.

Yoshihisa Hirakawa1, Yuichiro Masuda, Masafumi Kuzuya, Akihisa Iguchi, Takaya Kimata, Kazumasa Uemura.   

Abstract

BACKGROUND: The relation between diabetes mellitus (DM) and mortality among patients with acute myocardial infarction is still controversial. We evaluated the influence of DM on the in-hospital mortality of acute myocardial infarction (AMI) patients using data from the Tokai Acute Myocardial Infarction Study-II, a multi-hospital prospective study performed in Japan.
METHODS: All of the study subjects were patients hospitalized for newly diagnosed AMI at 1 of 13 acute care hospitals between January of 2001 and December of 2003. We abstracted the baseline and procedural characteristics from detailed chart reviews. Multivariate analysis was performed, controlling for the variables found to be significantly different between AMI patients with and without DM by chi-square test or unpaired t-test. We evaluated a total of 940 DM and 2284 non-DM patients.
RESULTS: DM patients had roughly twice the in-hospital mortality rate of non-DM patients, with an unadjusted odds ratio of 1.77 (95% CI, 1.37-2.30). However, according to the multivariate analysis, DM was not identified as an independent predictor of in-hospital death, with an adjusted odds ratio of 5.73 (95% CI, 0.97-33.88).
CONCLUSIONS: DM is not an independent predictor of in-hospital mortality, and that there is a need for additional studies to confirm our conclusion.

Entities:  

Mesh:

Year:  2006        PMID: 16762440     DOI: 10.1016/j.diabres.2006.04.011

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  Rural-urban differences in acute myocardial infarction mortality: Evidence from Nebraska.

Authors:  Soumitra Sudip Bhuyan; Yang Wang; Samuel Opoku; Ge Lin
Journal:  J Cardiovasc Dis Res       Date:  2014-02-22

2.  Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction who underwent successful percutaneous coronary intervention: results from the Korean Acute Myocardial Infarction Registry.

Authors:  Keun-Ho Park; Youngkeun Ahn; Myung Ho Jeong; Shung Chull Chae; Seung Ho Hur; Young Jo Kim; In Whan Seong; Jei Keon Chae; Taek Jong Hong; Myeong Chan Cho; Jang Ho Bae; Seung Woon Rha; Yang Soo Jang
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

3.  Trends of hospitalizations, fatality rate and costs for acute myocardial infarction among Spanish diabetic adults, 2001-2006.

Authors:  Ana Lopez-de-Andres; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Jesús Esteban-Hernandez; Angel Gil-de-Miguel; Rodrigo Jiménez-García
Journal:  BMC Health Serv Res       Date:  2010-03-08       Impact factor: 2.655

4.  National trends over one decade in hospitalization for acute myocardial infarction among Spanish adults with type 2 diabetes: cumulative incidence, outcomes and use of percutaneous coronary intervention.

Authors:  Ana Lopez-de-Andres; Rodrigo Jimenez-Garcia; Valentin Hernandez-Barrera; Isabel Jimenez-Trujillo; Carmen Gallardo-Pino; Angel Gil de Miguel; Pilar Carrasco-Garrido
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

5.  Renal Dysfunction was an Independent Predictor of In-Hospital Death and Ventricular Rupture in Patients With Acute Myocardial Infarction.

Authors:  Masayuki Goto; Eiji Oda; Hirooki Matsushita; Ken Takarada; Makoto Tomita; Atsushi Saito; Koichi Fuse; Satoru Fujita; Yoshio Ikeda; Hitoshi Kitazawa; Minoru Takahashi; Masahito Sato; Masaaki Okabe; Yoshifusa Aizawa
Journal:  Cardiol Res       Date:  2012-05-20

6.  Can ischemic stroke be caused by acute reduction of blood pressure in the acute phase of cardiovascular disease?

Authors:  Satoshi Hoshide; Kazuo Eguchi; Joji Ishikawa; Mitsunobu Murata; Takaaki Katsuki; Takeshi Mitsuhashi; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.